Tolerability of Transcutaneous Vagal Nerve Stimulation
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07735234
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- transcutaneous auricular vagus nerve stimulation (taVNS) — DEVICEThe participant will undergo 2-hour therapy sessions, 3 times per week, for 4 weeks for a total of 12 occupational therapy sessions with stimulation after the visit. Participants will receive 90 minutes of therapy per session. Stimulation will be delivered using a biphasic rectangular pulse, pulse width of 250 us, frequency of 25Hz, duty cycle of 30 seconds on / 30 seconds off during active therapy. 1 second ramp up and ramp down will be used to improve comfort. Maximum total stimulation per session will not exceed 45 minutes.
Study Details
The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.
Key Dates
- First listed
- Jul 29, 2026
- Start date
- Jul 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Sep 4, 2026
- Completion
- Sep 4, 2026
Study Design
- Enrollment
- 1 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: transcutaneous auricular vagus nerve stimulation (taVNS)
Primary Outcome Measure
Tolerability as assessed by the ability of the participant to complete the treatment protocol [ Time Frame: From baseline to end of treatment (5 weeks after baseline) ]
Central Contacts
- Stuart M Fraser, MD(713) 500-7142
- Melika A Abrahams(713) 500-6138
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By condition
By specialty
Related Studies
- Human-Machine System for the H2 Lower Limb ExoskeletonRecruiting · University of Houston · Houston, Texas
- Get With the Guidelines-Stroke RegistryRecruiting · American Heart Association · Dallas, Texas
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · La Jolla, California
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With StressPHASE4 · Recruiting · Population Health Research Institute · Los Angeles, California